"South America has become a new epicenter of the COVID-19 disease, certainly the most affected is Brazil at this point," Dr Mike Ryan, executive director of World Health Organization (WHO), told reporters on Friday.
"The current guidance for hydroxychloroquine does not support widespread use for COVID-19 until trials are complete," Ryan added, per Reuters, and noted that Brazil has approved wider use.
Market reaction
The USD/BRL pair largely ignored these remarks and was last seen gaining 0.2% on a daily basis at 5.5620.
作者：Eren Sengezer，文章来源FXStreet，版权归原作者所有，如有侵权请联系本人删除。
风险提示：本文所述仅代表作者个人观点，不代表 Followme 的官方立场。Followme 不对内容的准确性、完整性或可靠性作出任何保证，对于基于该内容所采取的任何行为，不承担任何责任，除非另有书面明确说明。
喜欢的话，赞赏支持一下
加载失败()